These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19962528)
21. Re: Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer s. P. Lerner, C. M. Tangen, H. Sucharew, D. Wood and E. D. Crawford J Urol 2007; 177: 1727-1731. Lamm DL J Urol; 2008 Feb; 179(2):788. PubMed ID: 18082825 [No Abstract] [Full Text] [Related]
22. The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder. Kim JC; Steinberg GD J Urol; 2001 Mar; 165(3):745-56. PubMed ID: 11176460 [TBL] [Abstract][Full Text] [Related]
23. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. Herr HW J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743 [TBL] [Abstract][Full Text] [Related]
24. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment]. Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268 [TBL] [Abstract][Full Text] [Related]
25. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer. Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798 [TBL] [Abstract][Full Text] [Related]
27. Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79. Nieder AM; Soloway MS; Jewett MA J Urol; 2007 Jul; 178(1):352. PubMed ID: 17507038 [No Abstract] [Full Text] [Related]
28. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Colombo R Eur Urol; 2007 Sep; 52(3):774-5. PubMed ID: 17434255 [No Abstract] [Full Text] [Related]
29. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Brausi M Eur Urol; 2007 Sep; 52(3):775-6. PubMed ID: 17434253 [No Abstract] [Full Text] [Related]
35. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [TBL] [Abstract][Full Text] [Related]
36. [T1 G3 bladder tumors: the respective role of BCG and cystectomy]. Pfister C; Landé P; Hervé JM; Barré P; Barbagelatta M; Camey M; Botto H Prog Urol; 1995 Apr; 5(2):231-7. PubMed ID: 7719369 [TBL] [Abstract][Full Text] [Related]
37. T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival. McHugh LA; Griffiths TR BJU Int; 2004 Jul; 94(1):193. PubMed ID: 15217467 [No Abstract] [Full Text] [Related]